Home
About
Publications Trends
Recent Publications
Expert Search
Archive
total body irradiation (tbi)
What Are the Indications for TBI?
TBI is most commonly indicated for patients undergoing a bone marrow or stem cell transplant for:
Acute lymphoblastic leukemia (ALL)
Acute myeloid leukemia (AML)
Chronic myeloid leukemia (CML)
Non-Hodgkin lymphoma
Hodgkin lymphoma
It is also used in some cases of
multiple myeloma
and other hematologic malignancies.
Frequently asked queries:
What is Total Body Irradiation (TBI)?
How Does TBI Work?
What Are the Indications for TBI?
What Are the Side Effects of TBI?
How is TBI Administered?
What are the Benefits of TBI?
Are There Alternatives to TBI?
Can GABA Receptors be Therapeutic Targets?
How is ISH Applied in Cancer Research?
What is the Role of Family in Understanding Genetic Predisposition?
What Are the Challenges in Tissue Segmentation?
How do State of the Art Reviews Contribute to Cancer Research?
What Role Do Moisturizers Play During Cancer Treatment?
Is Sunscreen Effective in Preventing Skin Cancer?
Can Neurological Changes Be Reversed?
What Role Does CareClinic Play in Lifestyle Management?
How Do Higher Data Speeds Benefit Cancer Research?
How to Prepare for Partial Laryngectomy?
What Services Do Cancer Counselors Offer?
Why is Respect for Persons Crucial in Cancer Care?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe